Fibrotic NASH score may help health care providers predict at-risk patients

A noninvasive scoring system using routine laboratory data may help primary care providers screen for fibrotic nonalcoholic steatohepatitis and dysmetabolism in high-risk patients, according to a published study. “A body of evidence shows that individuals with fibrotic NASH, the inflammatory form of [nonalcoholic fatty liver disease (NAFLD)] associated with significant activity and fibrosis, are at risk of developing advanced liver disease,” Federica Tavaglione, MD, of the department of internal medicine and geriatrics at Campus Bio-Medico University in Rome, and colleagues wrote

A noninvasive scoring system using routine laboratory data may help primary care providers screen for fibrotic nonalcoholic steatohepatitis and dysmetabolism in high-risk patients, according to a published study. “A body of evidence shows that individuals with fibrotic NASH, the inflammatory form of [nonalcoholic fatty liver disease (NAFLD)] associated with significant activity and fibrosis, are at risk of developing advanced liver disease,” Federica Tavaglione, MD, of the department of internal medicine and geriatrics at Campus Bio-Medico University in Rome, and colleagues wrote